[Mild cognitive impairment. Survey of attitudes of specialists and general physicians. mild]

Cecilia M Serrano1, Ricardo F Allegri, Paulo Caramelli

  • 1LLaboratorio de Investigación de la Memoria del Hospital A. Zubizarreta (GCBA), Buenos Aires, Argentina. 2 siren@cemic.edu.ar

Medicina
|April 6, 2007
PubMed

Insights

Mild cognitive impairment (MCI) is viewed as an ambiguous condition, not solely a pre-dementia stage of Alzheimer's disease (AD). Experts often initiate treatment for MCI, highlighting its complex nature and need for standardized diagnostic approaches.

Area of Science:

  • Neurology
  • Psychiatry
  • Gerontology

Context:

  • Mild cognitive impairment (MCI) is often considered a pre-dementia stage of Alzheimer's disease (AD).
  • However, MCI can also be associated with cerebro-vascular disease, frontotemporal dementia, or normal aging.
  • Diagnosis, etiology, and conversion to dementia present ambiguities in MCI.

Purpose:

  • To evaluate the opinions of dementia experts and general practitioners regarding Mild Cognitive Impairment (MCI).
  • To understand expert perspectives on MCI's nature, progression, and treatment.

Summary:

  • A questionnaire assessing MCI opinions was distributed to 24 experts (neurologists, psychiatrists) and 30 general practitioners in Argentina and Brazil.
  • 92% of experts viewed MCI as ambiguous, not exclusively a pre-dementia AD stage.
  • 63% observed a tendency for MCI to worsen, and 83% initiated treatments like cholinesterase inhibitors, memantine, and vitamin E.

Impact:

  • Findings suggest MCI is a heterogeneous entity requiring standardized definitions and diagnostic guides.
  • Expert opinions indicate a need to broaden the understanding of MCI beyond just an Alzheimer's pre-dementia phase.
  • This research highlights the clinical ambiguity surrounding MCI and the varied approaches to its management.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...